Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA056060-05
Application #
2097053
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1992-02-07
Project End
1997-01-31
Budget Start
1996-02-01
Budget End
1997-01-31
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305

  Publications

Advani, R H; Hoppe, R T; Baer, D et al. (2013) Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial. Ann Oncol 24:1044-8
Koontz, Michael Zach; Horning, Sandra J; Balise, Raymond et al. (2013) Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials. J Clin Oncol 31:592-8
Advani, Ranjana H; Hoppe, Richard T; Maeda, Lauren S et al. (2011) Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience. Int J Radiat Oncol Biol Phys 81:1374-9
Ekstrand, Bradley C; Lucas, Jennifer B; Horwitz, Steven M et al. (2003) Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. Blood 101:4285-9
Horning, Sandra J; Hoppe, Richard T; Breslin, Sheila et al. (2002) Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial. J Clin Oncol 20:630-7
Donaldson, S S; Hancock, S L; Hoppe, R T (1999) The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects. Cancer J Sci Am 5:325-33
Yuen, A R; Rosenberg, S A; Hoppe, R T et al. (1997) Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. Blood 89:814-22
Horning, S J; Hoppe, R T; Mason, J et al. (1997) Stanford-Kaiser Permanente G1 study for clinical stage I to IIA Hodgkin's disease: subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. J Clin Oncol 15:1736-44
Rosenberg, S A (1996) The management of Hodgkin's disease: half a century of change. The Kaplan Memorial Lecture. Ann Oncol 7:555-60
Horning, S J; Rosenberg, S A; Hoppe, R T (1996) Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update. Ann Oncol 7 Suppl 4:105-8

Showing the most recent 10 out of 14 publications